The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 06, 2015
Filed:
Aug. 03, 2012
Applicants:
John W. Babich, Cambridge, MA (US);
Craig Zimmerman, Topsfield, MA (US);
John L. Joyal, Melrose, MA (US);
Genliang LU, Winchester, MA (US);
Inventors:
John W. Babich, Cambridge, MA (US);
Craig Zimmerman, Topsfield, MA (US);
John L. Joyal, Melrose, MA (US);
Genliang Lu, Winchester, MA (US);
Assignee:
Molecular Insight Pharmaceuticals, Cambridge, MA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/04 (2006.01); A61K 49/00 (2006.01); C07F 5/00 (2006.01); C07D 257/02 (2006.01); C07D 255/02 (2006.01);
U.S. Cl.
CPC ...
C07D 257/02 (2013.01); C07F 5/003 (2013.01); A61K 51/0478 (2013.01); A61K 49/0002 (2013.01); A61K 51/0482 (2013.01); C07D 255/02 (2013.01);
Abstract
Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity: The invention also provides pharmaceutical compositions of a complex of a radionuclide and a Formula I compound or a Formula II compound and methods of using the radionuclide complex of a Formula I compound or a Formula II compound for treating or diagnosis of a disease or a condition associated with PSMA activity.